同期调强放疗联合内分泌治疗对局部晚期前列腺癌乏力症状的影响  

Effect of Intensity Modulated Radiotherapy Combined with Hormonal Therapy on Fatigue in Patients with Locally Advanced Prostate Cancer

作　　者：骆华春[1] 傅志超[1] 冯静[1] 程惠华[1] 雷勇[2] 廖绍光[1] 沈志勇[1] 李睿[1] 

机构地区：[1]南京军区福州总医院放疗科,福州350025 [2]南京军区福州总医院医务部,福州350025

出　　处：《肿瘤防治研究》2016年第6期502-507,共6页Cancer Research on Prevention and Treatment

基　　金：中华医学基金会(314.2213);南京军区福州总医院院内课题(2014Q23)

摘　　要：目的评价调强放疗联合内分泌治疗对局部晚期前列腺癌乏力症状的影响。方法对符合纳入标准的局部晚期前列腺癌患者采用同期三维适形调强放疗联合内分泌治疗。采用FSI(Fatigue Symptom Inventory)量表进行长期问卷随访,调查时间分别为治疗前(A)、治疗结束后(B)、治疗结束3月(C)、12月(D)、24月(E)、36月(F)、48月(G)。随访内容包括疲劳程度、对生活质量影响程度及上周疲劳持续时间3个维度。Logistic多分类回归模型评价危险因素。结果共97例局部晚期前列腺癌患者纳入研究。中位随访时间43.9月。乏力指数与PSA水平、Gleason评分、ECOG评分及文化程度相关(P<0.05);年龄和临床分期与乏力指数无关(P>0.05);多分类回归分析显示P S A水平和E C O G评分是癌症相关性乏力的独立危险因素。疲劳程度在各个随访时间点未体现出差异(P>0.05),但最严重疲乏程度发生在时间点B和C;时间点C、D、E、F和G的疲乏对生活影响积分均高于基线评价,且差异有统计学意义(P<0.05),尤其是对日常活动影响积分、注意力积分和情绪积分。疲乏持续时间呈现波动状态,时间点D、E、F呈明显上升,差异有统计学意义(P<0.05)。结论ECOG评分高、Gleason≥8分、PSA>20ng/ml、且文化程度高的局部晚期前列腺癌患者,在接受同期放疗联合内分泌治疗后,要关注乏力对生活质量产生的影响,特别是在对日常活动、注意力和情绪方面。Objective To evaluate the effect of intensity modulated radiotherapy（IMRT） combined with hormonal therapy on fatigue in patients with locally advanced prostate cancer. Methods IMRT combined with hormonal therapy were administered to the patients with locally advanced prostate cancer who met the inclusion criteria. Long-term follow-up was performed using the Fatigue Symptom Inventory（FSI） before treatment（A）, at the end of IMRT（B）, and three months（C）, 12 months（D）, 24 months（E）, 36 months（F）, and 48 months（G） after IMRT. Three dimensions of fatigue were assessed during follow-up： severity, perceived interference with quality of life, and duration in the past week, meanwhile, we used Cox regression model to evaluate the risk factors. Results Totally, 97 patients were enrolled from February 2007 to November 2013. Median follow-up time was 43.9 months. The fatigue index was related to the factors of PSA, Gleason, ECOG and education（P〈0.05）, however, not related to the age or TNM staging（P〈0.05）. PSA and ECOG score were the independent risk factors of cancer-related fatigue. No significant difference was measured in fatigue among each follow-up time points（P〈0.05）, but the most severe fatigue occurred at time points B and C. The score for interference with quality of life was significantly higher at each followup time points after the radiotherapy than the baseline（P〈0.05）, especially the scores for interference with general level of activity, ability to concentrate and mood. The score for duration of fatigue fluctuated across the time points, with significantly increased scores at time points D, E, and F（P〈0.05）. Conclusion For locally advanced prostate cancer patients with a high ECOG score, a Gleason score 8 points, PSA levels 20 ng/ml and high education, the attention should be paid to the interference of fatigue with quality of life, especially general level of activity, ability to concentrate and mood, after radiotherapy combined with hormonal

关 键 词：前列腺癌 癌症相关性乏力 放射治疗 内分泌治疗 

分 类 号：R730.55[医药卫生—肿瘤]